Alexander S. Vasilyev
Saint Petersburg, SPE, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Effectiveness and safety of brolucizumab in the treatment of neovascular age-related macular degeneration
Journal: Vestnik oftalmologii
Published: September 10, 2024
Plain language summary of the HIMALAYA study: tremelimumab and durvalumab for unresectable hepatocellular carcinoma (liver cancer).
Journal: Future oncology (London, England)
Published: September 06, 2023
Short-term experience of intravitreal brolucizumab in treatment of diabetic macular edema
Journal: Vestnik oftalmologii
Published: March 16, 2023
Durvalumab with or without tremelimumab versus the EXTREME regimen as first-line treatment for recurrent or metastatic squamous cell carcinoma of the head and neck: KESTREL, a randomized, open-label, phase III study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: August 12, 2022
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma.
Journal: NEJM evidence
Published: August 01, 2022
Rapid quasi-periodic oscillations in the relativistic jet of BL Lacertae.
Journal: Nature
Published: January 29, 2022
Spatial Distribution of Eye-Movements After Central Vision Loss is Consistent with an Optimal Visual Search Strategy.
Journal: International journal of neural systems
Published: November 13, 2019
Blazar spectral variability as explained by a twisted inhomogeneous jet.
Journal: Nature
Published: June 22, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026